This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

ACL fails attempt to dismiss privacy allegations in data-breach case

By Saloni Sinha ( February 4, 2025, 06:58 GMT | Insight) -- Pathology-services provider Australian Clinical Labs suffered a setback in its legal dispute with the privacy regulator today, after an Australian judge dismissed its application to strike out a claim that it contravened a civil penalty provision in the privacy law approximately 21.5 million times — the number of individuals allegedly affected by a February 2022 data breach. During a Federal Court of Australia hearing today, the judge said he was not convinced ACL's defense would significantly change whether the case was presented as one large violation or multiple smaller ones.  Australian Clinical Labs, or ACL, suffered a setback in its legal dispute with the privacy regulator today when an Australian judge dismissed the company's request to strike out certain allegations in a data-breach lawsuit. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections